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Abstract
Pathogenic germline mutations in ELN can be detected in patients with supravalvular aortic 
stenosis. The mutation might occur de novo or be inherited following an autosomal dominant 
pattern of inheritance. In this report we describe a three-generation family suffering from 
supravalvular aortic stenosis, various other arterial stenoses, sudden death, and intracranial 
aneurysms. A frameshift mutation in exon 12, not described before, was detected in the affected 
family members. This report emphasises the importance of family history, genetic counselling, and 
demonstrates the great variability in the phenotype within a single SVAS family.
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Introduction
Supravalvular aortic stenosis (SVAS) is a congenital narrowing of the ascending aorta and 
has an incidence of 1:20000. SVAS often occurs sporadically 1. A non-syndromic, hereditary 
form of SVAS has been known since 1964 when Eisenberg et al described several cases with 
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more than one affected generation 2. The autosomal dominant condition was later linked to 
chromosome 7q11.2 and point mutations were found in the elastin gene (ELN) in affected 
families 3. Thus, the condition can be classified as an autosomal dominant inherited elastin 
arteriopathy (OMIM 185500). A syndromic form of SVAS includes Williams syndrome, 
which is caused by a microdeletion encompassing ELN, and characterized by dysmorphic 
features, intellectual disability, and SVAS. Over the years, the phenotypic spectrum of ELN 
related clinical features has been broadened. In this report, we describe a new genotype-
phenotype correlation with a case of an intracranial aneurysm (IA).
Patient report
The proband, a 38-year-old male patient, was referred to genetic counselling because of a 
family history of congenital heart defect (Figure 1).
Medical history
The proband (III-3) was born at term after an uncomplicated pregnancy. Birth length was 50 
cm and birth weight was 2750 g. At 13 months, he was referred to the paediatric department 
because of a systolic heart murmur. He was diagnosed with a non-specified congenital heart 
defect but had normal development. He did not have a syndromic appearance. In his medical 
records it is stated that at age 2, a cardiac catheterization showed SVAS and a hypoplastic 
aortic arch, but details from the catheterization are no longer available. During childhood the 
patient suffered from recurrent pneumonias and an inguinal hernia. At 6 years of age, repeat 
heart catheterization found the SVAS with a gradient of 190 mmHG and he underwent heart 
surgery with Dacron patch aortoplasty in the ascending aorta. At this age, he experienced 
limitations in physical activity. Postoperative complications included occlusion of the right 
femoral artery. The patient had normal developmental milestones and attended regular 
school.
At 16 years of age, he underwent heart surgery again because follow-up cardiac 
investigation had shown a remaining stenosis SVAS of 53 mmHg and a hypoplastic aortic 
arch, stenosis of the brachiocephalic artery, and stenosis of the left common carotid artery, 
without reference to gradients in the latter. Minor central pulmonary artery stenoses of 27 
mmHg on the left and 10 mmHg on the right side are documented. Heart valves were normal 
and renal angiography showed a normal variation of the arterial supply with two renal 
arteries to the right kidney and one to the left. The patient was operated with an extension of 
the previous aortotomy of the ascending aorta with a new Dacron patch extending y-shaped 
into the right and non-coronary sinuses and going up into the proximal brachiocephalic 
trunk, but omitting surgery on the left common carotid artery.
At age 20, the proband was admitted to hospital because of a sudden pain in the neck, 
vomiting, and nausea. He was diagnosed with a subarachnoid haemorrhage. Cerebral 
angiography of the brain showed an aneurysm in the anterior communicating artery. The 
aneurysm was ligated without complications and the proband had no long-term disability. At 
age 27, genetic testing for Williams syndrome showed normal results. When the patient was 
37 year old he was referred to the department of clinical genetics, because his new-born 
daughter (IV-2) was diagnosed with a congenital heart defect, which raised suspicion of a 
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monogenetic condition. The proband was reexamined by echocardiography, and, 
subsequently, left heart catheterization, as no signs of remaining pulmonary stenosis were 
seen on echocardiography, but he had hypertension and suspicion of renewed SVAS. 
Invasive gradients were only 15 mmHg from the left ventricle to the descending aorta, 
however, and attends biannual follow-up.
II-2, the mother of the proband (III-3), was diagnosed with congenital heart disease at the 
age of 10, which was later confirmed to be SVAS. The diagnostic tools used are not 
described in later records, but from her age at diagnosis, probably by heart catheterization, 
and in more recent records commenting on echocardiographs, only a minor aortic stenosis of 
20 mmHg along with severe hypertrophy owing to severe hypertension, was described. She 
had normal levels of physical activity and never underwent surgery. She suffered from severe 
migraine during adulthood. At age 58 she experienced weakness in both the upper and lower 
extremity on the left side of the body, but was not examined further. During workup for 
severe headache a year later she was diagnosed with and treated for hypertension. 
Furthermore, she had a CT scan of the brain performed, showing an old stroke in the right 
hemisphere, and unrelated to this, a borderline narrowing of maximum 49% of the left 
internal carotid artery on duplex scanning.
IV-2, the second daughter of III-3, was referred to the paediatric department five hours after 
birth because of a heart murmur. She was delivered naturally at term. Birth weight was 4428 
g and birth length was 54 cm. Echocardiography revealed a patent ductus arteriosus and 
stenoses of the pulmonary arteries with gradients on echocardiography and subsequent heart 
catheterization of 50–60 mmHg and prolonged narrowing of the central sections. No other 
stenoses were discovered, the ductus closed spontaneously, and the patient was referred to 
surveillance. At age one, she was admitted to the paediatric department because of suspicion 
of diabetes mellitus type 1 which was confirmed. Development milestones were normal and 
she experienced no limitations in physical activity.
Additional family history
A detailed family history revealed that III-3’s older brother died at two month of age. He 
was cyanotic at birth, which improved over the first week of life. Cardiac catheterization on 
day 11 showed pulmonic stenosis with only a narrow passage and an atrial septal defect. He 
died at two month of age. No autopsy was performed and we do not have further clinical 
descriptions.
Furthermore, III-3’s maternal grandmother had died suddenly at age 38.
Material and methods
The autosomal dominant pattern of inheritance with several generations with stenoses of the 
great arteries raised suspicion of an ELN mutation. DNA from blood samples from III-3 was 
analysed by direct sequencing. The entire coding region of ELN and flanking intronic 
regions were sequenced. All sequence data were obtained using ABI Big DYE v3.1 
terminator kit and 3730xl automated sequencer and the results were analysed using the 
Sequencher 4.5 software (GeneCodes, Ann Arbor, MI).
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Results
A heterozygous frameshift mutation was detected in exon 12: chr7:74,046,732dupC 
(GRC38/hg19) c.608dupC, (ENST00000358929), p.L204Tfs*58, that has not been 
described before. The duplication creates a frameshift and induces a premature stop codon. 
Segregation analysis in the family revealed that the affected family members II-2 and IV-2 
also carried the mutation. Samples from III-1 and I-4 were not available for genetic analysis. 
The mutation was considered pathogenic due to the nature of the mutation (frameshift, 
premature stop codon) and because the mutation segregates with affected family members. 
The mutation is not listed in ExAC and the population frequency is unknown.
Discussion
This report demonstrates the broad phenotypic spectrum of autosomal dominant inherited 
elastin arteriopathy. In this family, both connective tissue lesions such as inguinal hernias 
and severe arterial conditions are present. Two family members (I-4 and III-1) died 
suddenly, and although it was not possible to perform mutation analysis in these individuals, 
we suspect them to have had the ELN mutation. The risk of sudden cardiac death in ELN 
related arteriopathy is unknown, but Metcalfe et al. reported one case of sudden infant death 
1
. We also report the occurrence of subarachnoid haemorrhage caused by an IA (III-3). This 
is interesting, as ELN has been implicated in the genetic risk of IAs by linkage and 
association studies 4–7, but not in all 8. To the best of our knowledge, IA in a patient with an 
ELN point mutation has not been reported previously. As ELN mutations seems to result in a 
general arterial disease, IA may be part of the condition, however co-occurrence by chance 
in the patient cannot be excluded.
The molecular disease mechanisms of ELN related SVAS are beginning to emerge. 
“Premature stop codons in ELN may lead to nonsense-mediated mRNA decay, and thereby 
decreased levels of ELN and thus result in functional haploinsufficiency as it has been 
described for Williams syndrome.”9,10. Reduced elastin availability during vascular 
maturation results in increased cell proliferation 11, as a result of excessive integrin β3 
signaling 12.
Autosomal dominant cutis laxa (OMIM 123700) is commonly caused by pathogenic 
mutations in ELN. This condition is characterized by loose/wrinkled skin, which lacks 
elastic recoil. Hernias, pulmonary emphysema, pulmonary artery stenoses, and aortic 
aneurysms have also been described in these patients 13,14. The molecular mechanism, 
however, has been suggested to be a mutant protein (tropoelastin) in which the C-terminus is 
replaced by an extended missense peptide sequence as a result of a frameshift mutation 
within any of the last 5 exons of ELN 15.
Our family demonstrates the great intrafamiliar variability. This illustrates that (suspicion of) 
the diagnosis is more difficult in less affected individuals/families. We propose that any 
history of cardiovascular symptoms in family member of a patient with SVAS should lead to 
consideration of a hereditary form of SVAS. In addition to point mutations and deletions of 
ELN, SVAS has been observed in patients with autosomal recessive cutis laxa type IA, 
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caused by mutations in the fibulin-5 (FBLN5) gene 16. Furthermore, arterial stenoses are 
known to be associated with a larger group of disorders, with pulmonary artery stenoses 
found in Alagille syndrome, and Noonan Syndrome, and renal artery stenoses in 
Neurofibromatosis type 1 17, which should also be considered if other symptoms are present.
A syndromic form of SVAS should be considered if the case appears to be de novo and if 
other symptoms e.g. dysmorphic features and developmental delay are present. When 
diagnosed, autosomal dominant inherited elastin arteriopathy should be regarded as a 
generalized disease of the arterial wall, which, in principle, could affect any artery in the 
body. This highlights the need for further clinical investigations, genetic counselling, and 
surveillance in affected patients and asymptomatic mutation carriers.
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Figure 1. (A) Pedigree of the family; (B) DNA sequence analysis of affected family members
Sequence traces of a control individual and II-2, III-3 and IV-2 are shown stacked. Above 
the sequence traces the wild-type (WT) protein and DNA sequences are aligned with the 
mutant (MT) sequences.
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